Page last updated: 2024-10-25

ciprofloxacin and Adenocarcinoma of Lung

ciprofloxacin has been researched along with Adenocarcinoma of Lung in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fawzy, MA1
Abu-Baih, RH1
Abuo-Rahma, GEA1
Abdel-Rahman, IM1
El-Sheikh, AAK1
Nazmy, MH1
Bykowska, A1
Komarnicka, UK1
Jeżowska-Bojczuk, M1
Kyzioł, A1

Other Studies

2 other studies available for ciprofloxacin and Adenocarcinoma of Lung

ArticleYear
In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway.
    Molecules (Basel, Switzerland), 2023, Jan-23, Volume: 28, Issue:3

    Topics: Adenocarcinoma of Lung; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation;

2023
Cu
    Journal of inorganic biochemistry, 2018, Volume: 181

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt

2018